Viridian Therapeutics Stock (NASDAQ: VRDN) stock price, news, charts, stock research, profile.
You can purchase shares of Viridian Therapeutics (NASDAQ:VRDN) through any online brokerage.
There are no as such competitors for Viridian Therapeutics.
Viridian Therapeutics has a consensus price target of $38.73.
The stock price for Viridian Therapeutics (NASDAQ: VRDN) is $19.21 last updated January 28, 2025 at 4:17 PM EST.
There are no upcoming dividends for Viridian Therapeutics.
Viridian Therapeutics’s Q4 earnings are confirmed for Tuesday, February 25, 2025.
There is no upcoming split for Viridian Therapeutics.
Viridian Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.